Intangible Assets - Additional Information (Details) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Nov. 30, 2018	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2018	Dec. 31, 2022		Mar. 04, 2022	May 31, 2021
Finite-Lived Intangible Assets [Line Items]
Amortization expenses			$ 600	$ 600	$ 1,800	$ 1,800
Amortization expenses, remainder period			600		600
Amortization expenses, 2024			2,400		2,400
Amortization expenses, 2025			2,400		2,400
Amortization expenses, 2026			2,400		2,400
Amortization expenses, 2027			2,400		2,400
Amortization expenses, thereafter			16,700		16,700
Capitalization of finite-lived intangible asset			32,500		32,500			$ 32,500
Accrued professional and other accrued liabilities			27,885		27,885			26,980	[1]
Other long-term liabilities			11,785		11,785			26,643	[1]
Foundation Medicine Diagnostics Agreement | Foundation Medicine, Inc
Finite-Lived Intangible Assets [Line Items]
Capitalization of finite-lived intangible asset											$ 12,500
Payment Following FDA Approval of Truseltiq
Finite-Lived Intangible Assets [Line Items]
Capitalization of finite-lived intangible asset											$ 20,000
QED Therapeutics, Inc
Finite-Lived Intangible Assets [Line Items]
Accrued professional and other accrued liabilities			6,000		6,000			2,500
Other long-term liabilities			$ 5,000		$ 5,000			$ 8,500
QED Therapeutics, Inc | Foundation Medicine Diagnostics Agreement | Foundation Medicine, Inc
Finite-Lived Intangible Assets [Line Items]
Potential regulatory milestone payments	$ 12,500
Regulatory milestone payments term	4 years
QED Therapeutics, Inc | Maximum
Finite-Lived Intangible Assets [Line Items]
Potential regulatory milestone payments							$ 60,000
Potential sales milestone payments							35,000
Origin Biosciences, Inc. | Maximum
Finite-Lived Intangible Assets [Line Items]
Potential sales milestone payments							17,000
Assets acquisition required milestone payments							$ 15,000
Origin-Sentynl APA
Finite-Lived Intangible Assets [Line Items]
Assets acquisition required milestone payments		$ 1,000
Derecognition of capitalized intangible asset net.		$ 13,500
Origin-Sentynl APA | Maximum
Finite-Lived Intangible Assets [Line Items]
Potential sales milestone payments										$ 4,500

[1] The condensed consolidated balance sheet as of December 31, 2022 is derived from the audited consolidated financial statements as of that date.